Murine double minute 2 (MDM2) small molecule inhibitor Nutlin-3 significantly enhanced SOCS1 mRNA levels concurrent with downregulation of miR-155 levels in both, primary B-CLL cells and B-CLL cell lines in vitro [153]. This evidence concerns the gene SOCS1 and B-cell chronic lymphocytic leukemia.